INVITRO EFFECT OF ESTRADIOL ON THYMIDINE UPTAKE IN PULMONARY VASCULAR SMOOTH-MUSCLE CELL - ROLE OF THE ENDOTHELIUM

被引:46
作者
FARHAT, MY [1 ]
VARGAS, R [1 ]
DINGAAN, B [1 ]
RAMWELL, PW [1 ]
机构
[1] GEORGETOWN UNIV, MED CTR, DEPT PHYSIOL & BIOPHYS, WASHINGTON, DC 20007 USA
关键词
ESTROGEN; ENDOTHELIUM; PULMONARY; VASCULAR SMOOTH MUSCLE; H-3]-THYMIDINE UPTAKE; TAMOXIFEN;
D O I
10.1111/j.1476-5381.1992.tb14506.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effect of different concentrations of oestradiol-17beta (3 300 nm) on [H-3]-thymidine uptake was studied in segments from canine pulmonary artery, and cultures of rat pulmonary vascular smooth muscle cells (VSMC). 2 Incubation with oestradiol-17beta for 24 h, potentiated in a concentration-dependent manner [H-3]-thymidine uptake in VSMC cultures. 3 Oestradiol-17beta potentiated thymidine uptake by pulmonary arterial segments but only when the endothelium had been removed. Autoradiography showed dense incorporation of radioactive thymidine in the vascular smooth muscle cells of the media. 4 The non-steroidal oestrogen, stilboestrol (300 nm), also significantly potentiated [H-3]-thymidine uptake, in both VSMC cultures and pulmonary artery segments. Testosterone was ineffective at a similar concentration. 5 Pre-incubation of the pulmonary VSMC with the anti-oestrogen tamoxifen (I mum) antagonized the potentiating effect of oestradiol-17beta on [H-3]-thymidine incorporation. The effect of tamoxifen was less pronounced in pulmonary arterial segments. 6 These data suggest that oestrogen may promote proliferation of pulmonary VSMC. Endothelial injury or dysfunction may be an important factor in the expression of the oestrogenic effect. 7 We speculate that plasma oestrogen may be a contributing factor to the proliferative lesion observed in certain forms of pulmonary vascular injury in women.
引用
收藏
页码:679 / 683
页数:5
相关论文
共 33 条
[1]   ESTROGEN REGULATION OF SPECIFIC MESSENGER-RNA IN HUMAN-BREAST CANCER-CELLS [J].
ADAMS, DJ ;
EDWARDS, DP ;
MCGUIRE, WL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1980, 97 (04) :1354-1361
[2]   ESTROGENS STIMULATE CELL-PROLIFERATION AND INDUCE SECRETORY PROTEINS IN A HUMAN-BREAST CANCER CELL-LINE (T47D) [J].
CHALBOS, D ;
VIGNON, F ;
KEYDAR, I ;
ROCHEFORT, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 55 (02) :276-283
[3]   INHIBITION OF MYOINTIMAL HYPERPLASIA AND MACROPHAGE INFILTRATION BY ESTRADIOL IN AORTA ALLOGRAFTS [J].
CHENG, LP ;
KUWAHARA, M ;
JACOBSSON, J ;
FOEGH, ML .
TRANSPLANTATION, 1991, 52 (06) :967-972
[4]  
CLARKSON TB, 1990, OBSTET GYNECOL, V75, P217
[5]  
COHEN D R, 1989, Critical Reviews in Oncogenesis, V1, P65
[6]  
DAVIDSON NE, 1989, ONCOGENESIS, V1, P89
[7]   INDUCTION OF EPIDERMAL GROWTH FACTOR-RELATED POLYPEPTIDES BY 17-BETA-ESTRADIOL IN MCF-7 HUMAN-BREAST CANCER-CELLS [J].
DICKSON, RB ;
HUFF, KK ;
SPENCER, EM ;
LIPPMAN, ME .
ENDOCRINOLOGY, 1986, 118 (01) :138-142
[8]   THE EFFECT OF ESTRADIOL ON THE PROLIFERATION OF RABBIT AORTIC MEDIAL TISSUE-CULTURE CELLS INDUCED BY HYPERLIPEMIC SERUM [J].
FISCHERDZOGA, K ;
WISSLER, RW ;
VESSELINOVITCH, D .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1983, 39 (03) :355-363
[9]  
FOEGH ML, 1987, TRANSPLANT P, V19, P90
[10]   THE EFFECT OF ESTROGEN AND TAMOXIFEN ON HEPATOCYTE PROLIFERATION INVIVO AND INVITRO [J].
FRANCAVILLA, A ;
POLIMENO, L ;
DILEO, A ;
BARONE, M ;
OVE, P ;
COETZEE, M ;
EAGON, P ;
MAKOWKA, L ;
AMBROSINO, G ;
MAZZAFERRO, V ;
STARZL, TE .
HEPATOLOGY, 1989, 9 (04) :614-620